ArticleActa diabetologica2026
Diabetic retinopathy screening telemedicine-based compared with standard of care : an economic analysis in a pilot experience of Italian healthcare.
Article in Acta diabetologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aimed to provide an economic analysis of the Local Health Authority Turin 5 (ASL TO 5) teleophthalmology diabetic retinopathy screening program.
methodsA retrospective chart analysis was performed on the diabetologists' digital folder to compare the costs of ASL TO5 screening program to the Italian standard of care based on in-office examination by ophthalmologist . The total cost was calculated for the two methods of screening. Mean annual unadjusted cost data per patient have been calculated by type of cost component.
resultsThe study included 3,635 patients with diabetes mellitus screened for diabetic retinopathy (DR) in 2023-24. The total (direct and indirect) cost for teleophthalmology screening program was € 48,976 while the estimated cost for the same quantity of patients screened with traditional examination by ophthalmologist would have been € 148,486. The mean cost per patient of telescreening was € 13.5 ± 5.3 . Conversely traditional screening would have a mean cost € 40.9 ± 28 per patient (p-value < 0.001). DISCUSSION: Advances in telemedicine are enhancing the DR screening strategies. Telescreening showed cost-savings of approximately € 100,000 for the Local Health Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation Authority ASL TO5 over a period of 2 years and for a screened population of 3,635. Telemedicine-based screening emerges as a less costly solution for the Italian National Health Service and can improve accessibility and compliance to this procedure.
conclusionsThis study provides an economic analysis of teleophthalmology DR screening program and highlights significant implications for patients, healthcare professionals and policymakers.
Indexed as
Identifiers
41182400What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.